| Literature DB >> 26870097 |
You Zou1, Yu-Qin Deng2, Chang-Wu Xiao3, Yong-Gang Kong4, Yu Xu5, Ze-Zhang Tao6, Shi-Ming Chen7.
Abstract
OBJECTIVE: To investigate the clinical features of epistaxis in the posterior fornix of the inferior nasal meatus and compare the treatment outcomes of endoscopic surgery and conventional nasal packing for this intractable form of epistaxis.Entities:
Keywords: Electrocautery; Endoscopy; Epistaxis; Inferior nasal meatus; Posterior fornix
Year: 2015 PMID: 26870097 PMCID: PMC4744282 DOI: 10.12669/pjms.316.8340
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Fig.1Surgical intervention.
The bleeding points are not located in the olfactory fissure, sphenoethmoidal recess, or middle nasal meatus, as observed during nasal endoscopy (black arrow indicates the right middle turbinate and white arrow indicates the right inferior turbinate).
The inferior nasal concha is shifted by fracture to broaden the inferior nasal meatus (black arrow indicates the strip apparatus and white arrow indicates the right inferior turbinate).
The cut end of the right posterolateral nasal artery located in the posterior fornix of the inferior nasal meatus (white arrow indicates the right inferior turbinate and black arrow indicates the cut end of the artery).
The bleeding sites are treated using electrocautery until no active bleeding can be observed.
Characteristics of patients before surgery (surgery group) or nasal packing (packing group).
| Number | Surgery group | Packing group | P | |
|---|---|---|---|---|
| Total | 53 | 38 | 15 | |
| Gender (female: male) | 26:27 | 18:20 | 8:7 | 0.698 |
| Age (years) (mean±SD) | 49.5±12.7 | 53.1±10.9 | 0.340 | |
| History of epistaxis (absence: presence) | 46:7 | 33:5 | 13:2 | 0.990 |
| SBP (mmHg) | 134.7±24.5 | 135.5±25.7 | 0.915 | |
| DBP (mmHg) | 96.4±3.7 | 96.2±3.8 | 0.883 | |
| Hemoglobin (g/L) | 122.7±20.8 | 21.6±21.4 | 0.646 | |
| Anticoagulant medication (absence: presence) | 50:3 | 36:2 | 14:1 | 0.844 |
| History of hypertension (absence: presence) | 44:9 | 32:6 | 12:3 | 0.716 |
| Receiving dialysis (absence: presence) | 53:0 | 38:0 | 15:0 | 1.000 |
| Cerebral infarction (absence: presence) | 50:3 | 36:2 | 14:1 | 0.844 |
| Cardiac disorder (absence: presence) | 43:10 | 31:7 | 12:3 | 0.896 |
| Diabetes mellitus (absence: presence) | 48:5 | 36:2 | 12:3 | 0.101 |
| Malignant tumor (absence: presence) | 53:0 | 38:0 | 15:0 | 1.000 |
| Hepatic disorder (absence: presence) | 53:0 | 38:0 | 15:0 | 1.000 |
| Bronchial asthma (absence: presence) | 53:0 | 38:0 | 15:0 | 1.000 |
| Thyroid disorder (absence: presence) | 53:0 | 38:0 | 15:0 | 1.000 |
| Shock(absence: presence) | 52:1 | 38:0 | 14:1 | 0.111 |
| Hyperlipidemia (absence: presence) | 47:6 | 34:4 | 13:2 | 0.774 |
Compared with the packing group, there were no significant differences between the surgery and packing groups.
Incidence of re-bleeding, visual analogue scale score for the extent of discomfort and incidence of nasal cavity adhesion in the surgery and nasal packing group.
| Surgery group | Packing group | P | |
|---|---|---|---|
| Re-bleeding | 0 | 4 | 0.001 |
| Discomfort after the treatment | 2.4±1.4 | 7.6±1.0 | 0.001 |
| Adhesion of nasal cavity | 2 | 7 | 0.007 |
The re-bleeding, extent of discomfort and incidence of nasal cavity adhesion were significantly lower in the surgery group than in the packing group.